Current Chairman and CEO Robert Yates to step down as CEO Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its board of directors has appointed Chris Smith as Chief Executive Officer effective September 9, 2019.

Achieves top ranking for 4th consecutive year Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that, for the fourth consecutive year, its Ortho Care™ service and support program was ranked No. 1 in the diagnostics industry.

Company will head to the Golden State to showcase its new and next-generation products, including Ortho's VITROS ®  XT 7600 Integrated System Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it will present four scientific posters and co-sponsor two posters at

Entire Ortho-created menu of assays now available on Ortho’s latest-generation analyzer Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS® Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) has been granted

Improved assay quality with the use of monoclonal antibodies ; Enhanced robustness to potential interferences; Rule-in and rule-out clinical performance allows clinicians to efficiently assess heart failure patients Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced the

Ortho to host industry conferences: 'Lab Leader Summit' and 'Healthcare Management in a Digital World' Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, will host two regional conferences for Asian health care professionals in which top experts will examine trends in laboratory

See how ORTHO VISION® platforms can deliver enhanced patient care, more effective data and improved turnaround time Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, will discuss the latest trends and technology in transfusion medicine and introduce its newly installed regional

2-day summit will bring together top hospital executives and focus on patient safety and service excellence Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, in collaboration with Singapore Management University, will host the fourth annual Ortho-SMU C-Suite Summit.

Next-generation assay aids in diagnosing heart attacks faster and more accurately, and is enabled on the company's newest analyzer, the VITROS ®  XT 7600 Integrated System Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced CE Mark for its next-generation VITROS ®  High

Groundbreaking XT Microslides deliver accurate results from 2 simultaneous miniaturized tests, simplifying workflow and improving turnaround time in the lab Ortho Clinical Diagnostics' VITROS ®  XT MicroSlides, featuring new, multi-test technology that allows labs to run two tests simultaneously on